During the past decade, Azienda Ospedaliera di Perugia conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 26 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 18 clinical trials were completed. i.e. 34% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Azienda Ospedaliera di Perugia" #1 sponsor was "National Cancer Institute, Naples" with 10 trials, followed by "Bayer" with 7 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 108 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera di Perugia" #1 collaborator was "Mario Negri Institute for Pharmacological Research" with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Agenzia Italiana del Farmaco" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Azienda Sanitaria-Universitaria Integrata di Udine" with 2 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 60 trials.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera di Perugia" are "Ovarian Cancer" (8 trials), "Atrial Fibrillation" (4 trials), "Melanoma" (4 trials), "Non Small Cell Lung Cancer" (4 trials) and "Non-Small Cell Lung Cancer" (4 trials). Many other conditions were trialed in "Azienda Ospedaliera di Perugia" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliera di Perugia" are "Drug" (102 trials), "Other" (15 trials), "Device" (12 trials), "Procedure" (9 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Carboplatin" (6 trials), "Paclitaxel" (6 trials), "Erlotinib" (5 trials) and "paclitaxel" (5 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliera di Perugia" are 129 trials for "All" genders and 17 trials for "Female" genders.

Currently, there are NaN active trials in "Azienda Ospedaliera di Perugia". undefined are not yet recruiting, 34 are recruiting, 25 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 55 completed trials in Azienda Ospedaliera di Perugia, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliera di Perugia, 4 "Phase 1" clinical trials were conducted, 37 "Phase 2" clinical trials and 59 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 10 trials that are defined as “Not Applicable".

Azienda Ospedaliera di Perugia has several departments that took part in Clinical trials: "Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia; Oncologia Medica" - 32 trials, "AO di Perugia - Ospedale S. Maria della Misericordia; Clinica Neurologica" - 4 trials, "Istituto di Ematologia-C.R.E.O. (Centro di Ricerche Emato-Oncologich)" - 2 trials, "Internal and Cardiovascular Medicine - University of Perugia" - 2 trials